(Q38108396)

29 August 2017

title

Anti-β2-glycoprotein I antibodies (English)

1 reference

29 August 2017

Rohan Willis

1

1 reference

29 August 2017

Silvia S Pierangeli

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 May 2013

1 reference

Annals of the New York Academy of Sciences

29 August 2017

published in

1 reference

29 August 2017

volume

1285

1 reference

29 August 2017

page(s)

44-58

1 reference

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Platelets and the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Impaired fibrinolysis in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Mechanisms of antiphospholipid antibody-associated pregnancy complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Primary antiphospholipid syndrome: a low-grade auto-inflammatory disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of beta2-glycoprotein I: proof of concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Complete amino acid sequence of human plasma beta 2-glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Molecular cloning and mammalian expression of human beta 2-glycoprotein I cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Pathogenesis of the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Crystal structure of human β2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

β₂-glycoprotein I: a novel component of innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Viral infections and antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

[Antiphospholipid antibodies, antiphospholipid syndrome and viral infections].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Infections and vaccines in the etiology of antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Thrombogenic properties of antiphospholipid antibodies do not depend on their binding to beta2 glycoprotein 1 (beta2GP1) alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

The dual role of innate immunity in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Non-criteria manifestations of antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Annexin A2 mediates anti-beta 2 GPI/beta 2 GPI-induced tissue factor expression on monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Toll-like receptor (TLR)-4 mediates anti-β2GPI/β2GPI-induced tissue factor expression in THP-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

The binding site in {beta}2-glycoprotein I for ApoER2' on platelets is located in domain V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

{beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Mechanism of the interaction of beta(2)-glycoprotein I with negatively charged phospholipid membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Mode of interaction between beta2GPI and lipoprotein receptors suggests mutually exclusive binding of beta2GPI to the receptors and anionic phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Accelerated atherosclerosis in autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Induction of anti-β2-glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: Domain I of β2-glycoprotein I harbors a cryptic immunogenic epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

Anti–β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12080

21 January 2018

Identifiers

DOI

10.1111/NYAS.12080

1 reference

29 August 2017

1 reference